You just read:

Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

News provided by

Daiichi Sankyo Company, Limited

27 Apr, 2017, 14:00 BST